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Abstract
Background: Little is known about the association between air pollution and erectile dysfunction (ED), a disorder
occurring in 64% of men over the age of 70, and to date, no studies have been published. To address this
significant knowledge gap, we explored the relationship between ED and air pollution in a group of older men
who were part of the National Social Life, Health, and Aging Project (NSHAP), a nationally representative cohort
study of older Americans.
Methods: We obtained incident ED status and participant data for 412 men (age 57–85). Fine particulate matter (PM2.5)
exposures were estimated using spatio-temporal models based on participants’ geocoded addresses, while nitrogen
dioxide (NO2) and ozone (O3) concentrations were estimated using nearest measurements from the Environmental
Protection Agency’s Air Quality System. The association between air pollution and incident ED (newly developed in
Wave 2) was examined and logistic regression models were run with adjusted models controlling for race, education,
season, smoking, obesity, diabetes, depression, and median household income of census tract.
Results: We found positive, although statistically insignificant, associations between PM2.5, NO2, and O3 exposures and
odds of incident ED for each of our examined exposure windows, including 1 to 7 year moving averages. Odds ratios
(OR) for 1 and 7 year moving averages equaled 1.16 (95% CI: 0.87, 1.55) and 1.16 (95% CI: 0.92, 1.46), respectively, for an
IQR increase in PM2.5 exposures. Observed associations were robust to model specifications and were not significantly
modified by any of the examined risk factors for ED.
Conclusions: We found associations between PM2.5, NO2, and O3 exposures and odds of developing ED that did not
reach nominal statistical significance, although exposures to each pollutant were consistently associated with higher
odds of developing ED. While more research is needed, our findings suggest a relationship between air pollutant
exposure and incident cases of ED, a common condition in older men.
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Background
Erectile dysfunction (ED), defined as the inability of a
man to achieve or maintain an erection [1], is one of the
most common health conditions affecting older men.
Prevalence of ED is estimated to equal 20–40% in men
aged 60–69 years and 64% in men over the age of 70 [2],
with 617,715 new cases of ED expected each year in the
United States among white males between 40 and
69 years old [3]. With the aging of the population, it is
estimated that globally by the year 2025, over 320 mil-
lion men will have ED [4]. ED has a considerable impact
on quality of life, having been associated with a variety
of underlying psychological and physiological conditions,
such as depression, Type 1 and Type 2 diabetes mellitus,
use of medications, and cardiovascular disease [5]. How-
ever, ED is often left untreated, with as few as 10% of
men with ED receiving treatment [6]. Both treatment
and prevention of ED includes lifestyle modifications like
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exercise, weight loss, smoking cessation, and treatment
for comorbid conditions [5].
ED is a complex neurovascular process, influenced by
hormones and involves multiple pathways within the
body. ED is a predictor of occult and subclinical cardio-
vascular disease [7] that often occurs in 3 to 5 years after
ED diagnosis [7, 8]. Given this, it is not surprising that ED
has been shown to share a number of risk factors with car-
diovascular disease, including restricted blood flow and
vascular compromise with endothelial dysfunction at both
the macro and microvascular level [9, 10]. It is also plaus-
ible that ED shares other risk factors with cardiovascular
disease, including air pollutants such as fine particulate
matter (PM2.5; particles with aerodynamic diameters
≤2.5 μm) [11]. PM2.5 in particular has consistently been
shown to be strongly associated with cardiovascular mor-
bidity and mortality [12, 13]. The biological pathways
through which PM2.5 leads to cardiovascular damage is
thought to occur primarily through inflammation and oxi-
dative stress [14], leading to systemic vascular and endo-
thelial cell dysfunction [14, 15]. Whether PM2.5’s impacts
on systemic vascular dysfunction also lead to ED is un-
known. To our knowledge, no studies to date have been
published investigating the association between air pollu-
tion and ED. To address this significant knowledge gap,
we investigated the association between air pollution and
incident ED using a nationally representative cohort study




NSHAP is a longitudinal, population-based study of
community-dwelling older adults, who were selected for
participation based on a nationally representative prob-
ability sample of household-resident older adults aged
57–85 years, with oversampling of African-Americans,
Hispanics, men, and adults aged 75–84 years. Numerous
self-reported and biological measures of social, psycho-
logical, functional, and physiological health were col-
lected for each participant in each of two data collection
waves. The first wave (Wave 1) was conducted from July
2005 to March 2006, with in-home interviews, bio-
specimen collection, and respondent-completed ques-
tionnaires performed for 3,005 individuals (1,455 men).
The same data were obtained in Wave 2 (August 2010
to May 2011) for 3,377 participants (1,538 men), includ-
ing 2,261 respondents from Wave 1, 161 Wave 1 eligible,
but non-interviewed respondents, and 955 spouses or
cohabitating romantic partners. The overall weighted
response rate (weighted for differential probabilities of
selection and nonresponse) among the 2,261 individuals
(1068 men) who participated in both waves was 75.5%
and 76.9% for Waves 1 and 2 respectively, and interviews
were completed in English or Spanish as appropriate.[16]
The protocol was approved by the Institutional Review
Boards of Northeastern University, the University of
Chicago and NORC at the University of Chicago. All
respondents provided written informed consent.
ED measures
ED status was obtained through self-report to the ques-
tion asking men if “during the last 12 months has there
ever been a period of several months or more when you
had trouble getting or maintaining an erection?” This
question was administered only to men who reported
sexual activity within one year of the interview date in
Wave 1 and of all men in Wave 2. Information on ED
medication use and prostatectomy surgery was also col-
lected via questionnaire. Men were counted as having
ED if they answered yes to having ED or taking medica-
tions to treat ED. Incident cases were defined as men
who participated in both waves and developed ED
between Wave 1 and Wave 2.
Other covariates
Measures of height and weight were taken at the time of
the interview to calculate to body mass index (BMI), with a
BMI of 30 or greater kg/m2 defined as obese [17]. Addition-
ally, blood spot samples were collected and blood pressure
was measured for each participant (2–3 consecutive times)
during the home interview. Blood pressure was estimated
as the average of the repeated measurements, with hyper-
tension defined as having average systolic and diastolic
measurement of greater than 140 mmHg and 90 mmHg,
respectively [18]. C-Reactive Protein (CRP) was measured
from dried blood samples, and was considered elevated if
greater than 1 mg/L. Participants with CRP measurements
greater than 40 mg/L were not included in CRP analyses,
given the likelihood of an active infection [19].
In addition, information on medical conditions, like dia-
betes, and measures of activity, such as exercise and ability
to walk across a room, were obtained through participant
self-report. Measures of emotional health were also
obtained, with depression assessed using an eleven ques-
tion version of the Center for Epidemiological Studies –
Depression scale, CESD-11 [20]. A score of 9 or greater
on the CESD-11 was used to identify individuals with
“moderate-to-severe” depressive symptoms [20, 21].
Finally, information on census tract characteristics in-
cluding the tract median household income was obtained
from the 2010 US Census and matched to participants
based on their geocoded residence. A participant’s place of
residence was also used to determine the geographic
region of the United States in which they resided (West,
Midwest, Central, South, Northeast). The regional
divisions are based off of the Environmental Protection
Agency’s (EPA’s) regional planning organizations.
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Air pollution exposure assessment
Daily PM2.5 exposures were estimated on a 6 km (km) grid
covering the conterminous United States using a set of five
spatio-temporal generalized additive mixed models
(GAMMs) of daily PM2.5 mass levels fit separately to 1999–
2001, 2002–2004, 2005–2007, 2008–2009, and 2010–2011
based on previous work from Yanosky et al. [22]. PM2.5
data for the models were obtained primarily from the EPA’s
Air Quality System (AQS) database and Interagency Moni-
toring of Protected Visual Environments (IMPROVE) net-
work [23, 24]. The models included three meteorological
covariates (i.e., wind speed, temperature, and total precipi-
tation) that influence pollutant dispersion as well as several
geospatial covariates such as smoothed county population
density from the 2000 U.S. census, point-source PM2.5
emissions density within 7.5 km, proportion of urban land
use within 1 km, elevation, and annual-average PM2.5 for
2002 from EPA’s Community Multiscale Air Quality model.
Finally, the daily PM2.5 models include traffic-related PM
levels, represented as the output of a Gaussian line-source
dispersion modeling approach. The line-source model uses
ADMS-Roads software and associated spatially-smoothed
traffic intensity and daily meteorological inputs to describe
small-scale spatial gradients in primary PM concentrations
near roadways. The daily PM2.5 model was validated using
cross-validation techniques, as in Yanosky et al. [22], and
had a cross-validation R2 of 0.76. Cases and controls were
matched by date of interview to the PM2.5 grid values clos-
est to their residential addresses, taking into account moves
between waves. One to seven year moving averages from
the date of interview were calculated from the daily PM2.5
estimates. The mean distance between each grid
centroid–residential address pair was 2.23 km, with a
range of 0.05 – 4.21 km.
As secondary analyses, exposures to ozone (O3) and
nitrogen dioxide (NO2) were also estimated using data
from the EPA’s AQS. For both O3 and NO2, participants
were matched to the AQS monitor nearest to their resi-
dential address, provided that this monitor was located
within 60 km of the participant’s home. Air pollution ex-
posures were estimated for 93% (for O3) and 63% (for
NO2) of all male NSHAP participants. For NO2, 1–7
year moving averages from the date of interview were
calculated. For O3, 1–7 year average exposures preceding
the interview date were calculated based on the average
warm season (April-September) concentration, since O3
is measured at most monitoring sites only during
warmer months. Moving averages for each pollutant
were considered valid if ≥75% of the daily values within
each exposure window were available.
Statistical analyses
To investigate the association between chronic air pollu-
tant exposures and incident ED, we performed logistic
regression analyses, with the outcome of incident ED de-
fined as men reporting either ED or ED medication use
in Wave 2 but not Wave 1. Base models controlled for
covariates including age and geographic region, while
adjusted models additionally controlled for race/ethni-
city (white, black, Hispanic non-black, other), education
(proxy variable for socioeconomic status (SES), less than
high school, completed high school or vocational school,
college degree), current smoking status, obesity, dia-
betes, depression, season, and median household income
of the census tract. Covariates were included based upon
previous, known associations with either air pollution
exposures or ED. Results for all models are expressed as
the odds ratios (ORs) of having ED per interquartile
range (IQR) increase in ambient air pollution exposure.
Due to missingness in ED, BMI, and diabetes (39.6%
missing incident ED outcome in Wave 1 and 13.6% out-
come missing in Wave 2, 5.1% missing BMI in both
waves, and 0.6% missingness for diabetes in both waves),
we used multiple imputation to impute missing data.
We did so using the fully conditional specification (FCS)
algorithm with 100 imputed datasets created given the
logistic model and binary data used in the model [25].
Variables used in imputation included the outcome of
incident ED, any factors relating to ED (CRP, ability to
walk across a room, antiandrogens, and beta blockers) as
well as all covariates included in the model. Imputation
resulted in a data set containing all men who partici-
pated in both waves (n = 1068).
We examined effect modification of the association
between PM2.5 and incident ED by including separate in-
teractions between PM2.5 and obesity, hypertension, dia-
betes, CRP, exercise (as less or greater than once each
week), current smoking, and depression. These potential
modifiers were selected based on previous scientific
findings for air pollution and cardiovascular disease. All
effect modification analyses were performed for 4 year
moving average PM2.5 exposures since it was the interval
with the strongest observed effect estimate.
Sensitivity analyses were performed to examine the ro-
bustness of our findings to (1) alternate definitions of
ED and geographic region, (2) residential moves, (3)
treating ED as a reversible outcome, and (4) imputation
of ED data. We examined the robustness of our findings
with regard to our definition of ED as well as how the
geographic regions of the U.S. were defined. We did so
repeating our primary analyses but defining ED as only
those men who reported having ED (n = 129) as opposed
to also including men reporting ED medication usage
and by defining region based on 4 (North, South, East,
and West) as opposed to the 5 regions used in the pri-
mary analyses. We further assessed the sensitivity of our
findings to residential moves by restricting the analyses
to men who did not move during the study. Finally, to
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explore the relation of air pollution to ED prevalence
while treating ED as a reversible outcome [26], we in-
cluded all cases of ED (n = 746) in generalized mixed
models with random intercepts, rather than just incident
cases of ED. As before, models included adjustments for
age, race/ethnicity, education, year, season, current
smoking, obesity, diabetes, depression, median house-
hold income, and region. Similar to our primary ana-
lyses, additional covariates were selected based on
previous scientific findings to investigate effect modifica-
tion. Finally, complete case analyses were undertaken to
examine the potential effects of imputation.
All statistical analyses were conducted using SAS
version 9.4 software (SAS Institute Inc., Cary, North
Carolina). Statistical significance is reported at the two--
sided 0.05 level.
Results
In Wave 2, 132 men answered yes for the first time to
either having ED (129 men) or to ED medication use (10
men total, 3 men with medication usage alone), with
these men defined as incident ED cases for our study
period (Table 1). The number of incident ED cases was
small relative to the number of men reporting ED in
Wave 1, for which 331 men reported having ED and 29
reported being on ED medication. Over both waves, 280
men did not report developing ED and were the com-
parison group in our main analysis (Table 1). The major-
ity of men with incident ED were non-Hispanic White
(78.79%), with the average age of 70.3 years. Compared
to men without ED, those with ED were more likely to
be non-Hispanic Whites, have higher education levels,
and be obese. Other demographic characteristics of men
with and without ED were similar. One year mean mov-
ing averages for PM2.5 during Wave 2 were 8.9 μg/m
3
(±2.1) for men with ED and 8.6 μg/m3 (±2.3) for men
without ED. A comparison of men with and without
data for prevalent ED (provided in Additional file 1:
Table S1) showed that, depending on the wave, men dif-
fered significantly in the distribution of major risk
factors for ED including age, education, diabetes status,
obesity rates, depression and stress.
Table 2 presents the associations between incident ED
and moving average PM2.5 exposures over 1 to 7 years
prior to the interview date for both base and adjusted
models for imputed data. An IQR increase in 1 year
moving average PM2.5 exposure (3.25 μg/m
3) was associ-
ated with a 1.16 (95% CI: 0.87, 1.55) times higher odds
of developing ED, with similar results for an IQR
increase in the 7 year moving average exposure (3.10 μg/
m3, OR = 1.16 (95% CI, 0.92, 1.46)). The association be-
tween PM2.5 and ED was not significantly modified by
adverse health conditions, such as being obese or having
elevated CRP, diabetes, hypertension, depression, or by
behaviors such as current smoking or exercise (Table 3),
although the estimated ORs were consistently higher for
individuals without adverse health conditions.
As for PM2.5 exposures, 1–7 year moving averages of
O3 and NO2 exposures were positively associated with
odds of having incident ED, although associations did
not reach nominal statistical significance (Table 4). ORs
increased with longer moving averages, with the largest
odds ratio for O3 and incident ED observed for an IQR
increase in exposures averaged over 2 years (OR = 1.29,
95% CI, 0.93, 1.79).
Analyses conducted using different definitions of ED
and geographic regions as well as restricting analyses to
men who did not have residential moves between waves
showed qualitatively comparable results. For example,
including only those men who answered yes to the ED
question as men with incident ED (n = 129), in adjusted
models we found PM2.5-associated ORs ranging from
1.10 (95% CI, 0.75, 1.62) for an IQR increase in the 1 year
moving average exposure to 1.12 (95% CI, 0.82, 1.52) for
an IQR increase in the 7 year moving average exposure.
Analyses of all ED cases from both waves, assuming ED
is a reversible outcome, showed no statistically signifi-
cant association with pollutant exposures. For example,
the OR associated with IQR increases in PM2.5 7 year
moving average exposures was 1.06 (95% CI, 0.86, 1.30,
Additional file 1: Table S2).
Analyses restricted to complete cases (Additional File 1:
Table S3), had similar results to imputed data (Table 2)
but with slightly lower estimates. An IQR increase in 1 year
moving average PM2.5 exposure was associated with a 1.11
(95% CI: 0.76, 1.61) times higher odds of developing ED,
while an IQR increase in 7 year moving average PM2.5
exposure was associated with a 1.14 (95% CI: 0.84, 1.54)
times higher odds of developing ED.
Discussion
In our nationally representative study of older men, we
found that the odds of developing ED were higher but did
not reach nominal statistical significance for IQR increases
in PM2.5 exposures, with the 4 year moving average expos-
ure having the highest odds ratio (1.17, 95% CI: 0.91,
1.50). The observed associations between recent long-
term average PM2.5 level and ED were not significantly
modified by any of the examined risk factors for ED.
This study is the first to investigate the association
between incident ED and exposure to ambient air pollu-
tion. Although not statistically significant, we found
PM2.5 exposures to be consistently associated with
higher odds of developing ED. Our findings were con-
sistent across a broad range of sensitivity analyses. The
relatively small study size may in part account for the
imprecise estimates of association, as we had limited
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power to detect associations in the range of the observed
estimates.
Support for the hypothesis that ambient air pollution
may impact ED incidence is provided by epidemiologic
studies of cardiovascular outcomes, which have consist-
ently linked long-term PM2.5 exposure to vascular and
endothelial dysfunction, biological pathways that have
been linked to both ED and cardiovascular disease [27].
For example, a number of studies have found significant
associations between ambient PM2.5 and various mea-
sures of cardiovascular disease, including increased
blood pressure [28–30], stroke [31], brachial artery
reactivity to shear stress [15, 32], and atherosclerosis
[33–35]. Similarly, PM2.5 has also been shown to result
in endothelial dysfunction [36] and oxidative stress [37]
as assessed by measurements of the associated proteins
Tumor Necrosis Factor-alpha (TNF-α), intercellular ad-
hesion molecules (iCAM), and vascular cell adhesion
molecules (vCAM). In contrast to our findings, factors,
such as BMI [38] and diabetes [15] have been shown to
modify PM2.5 impacts on cardiovascular outcomes; how-
ever, our relatively small number of ED cases also likely
limited our ability to detect the presence of any effect
modification.
It is biologically plausible that exposure to PM2.5 can
lead to ED. Exposure to PM2.5 is associated with oxida-
tive stress and inflammation [36, 37], endothelial dys-
function [11], and atherosclerosis [33–35], potentially
causing ED of vascular origin through both arteriogenic
and veno-occlusive pathways [39]. Endothelial dysfunc-
tion and atherosclerosis, which are both strongly associ-
ated with ED, lead to damage in the arteries, reducing
blood flow to the penis [40]. Also, in erection biology,
oxidative stress and endothelial dysfunction cause a re-
duction in endothelial nitric oxide (NO) production,
leading to an increase in smooth muscle tone, impair-
ment of vasodilation, and impairment of the ability to
achieve an erection [9, 41]. Additional support comes
from animal models, where PM2.5 was shown to
decrease NO bioavailability, which is required for penile
erection [42].
Our findings that longer averages of 1 to 7 years are
associated with ED are supported by studies that show
higher risks for cardiovascular disease increases with
longer PM2.5 exposure windows [43]. Implications of
these findings are that adverse vascular effects of expos-
ure to PM2.5 are cumulative over time, progressively
leading to changes that manifest in a variety of vascular
disorders, including ED. It is also interesting to note that
we found lower, but still non-statistically significant
associations between exposure to PM2.5 and prevalent
cases of ED, possibly due to the fact that prevalent cases
of ED may have been present for many years and are
not related to the recent exposure windows used in
this study.
Our study has some potential limitations that warrant
discussion. First, the number of men with incident ED
(132) was relatively small. The number of men with inci-
dent ED may have been underestimated in Wave 1 given
that men were not asked about ED if they had no recent
sexual activity, possibly due to being impotent. This
Table 1 Characteristics of NSHAP Male Participants Included in
the Incident ED Studya
Characteristic Men with ED Men without ED P-valueb
Number of Participantsc 132 280
Age, mean (SD) 70.73 (6.27) 69.55 (6.06) 0.07
Race, n (%)
Non-Hispanic white 104 (78.79%) 186 (66.67%) 0.01
Non-Hispanic black 17 (12.88%) 39 (13.98%)
Hispanic non-black 8 (6.06%) 43 (15.41%)
Other 3 (2.27%) 11 (3.94%)
Region
Northeast 24 (18.18) 56 (20.07) 0.03
Southeast 37 (28.03) 54 (19.35)
Midwest 26 (19.70) 39 (13.98)
Central 18 (13.64) 47 (16.85)
West 27 (20.45) 83 (29.75)
Education Level, n (%)
Less than High School 11 (8.33%) 60 (21.43%) 0.004
H.S. or vocational school 74 (56.06%) 131 (46.79%)
College degree or greater 47 (35.61%) 89 (31.79%)
Median Household Incomed,
mean (SD)
58.97 (24.54) 61.09 (31.01) 0.49
Diabetes, n (%) 37 (28.42%) 44 (15.71%) 0.003
Hypertensione, n (%) 53 (40.46%) 120 (43.80%) 0.52
Elevated CRP, (>1), n (%) 86 (65.65%) 161 (57.91%) 0.14
BMI (kg/m2), mean (SD) 30.16 (5.66) 29.09 (5.37) 0.07
Exercise (weekly or more), n (%) 91 (68.94%) 197 (70.36%) 0.77
Current smoker, n (%) 17 (12.88%) 46 (16.43%) 0.35
Elevated depressionf, n (%) 23 (17.42%) 39 (13.93%) 0.35
PM2.5
g (μg/m3), mean (SD) 8.87 (2.12) 8.63 (2.30) 0.32
aStatistics are given for male participants from ED analysis, results are given as
n (%) or mean (SD)
bp values calculated for difference between groups using chi-square tests for
categorical variables and t-test for difference in means
cMen with ED are defined as subjects replying yes to ED question (129) or
reporting ED medication usage (10) in Wave 2 and not Wave 1 (7 men replied
yes to both); Men without ED are subjects who replied no to ED question and
ED medication use in both waves
dMedian household income is from census tract of each participant, results
given in thousands of dollars
e>90 mmHg diastolic and/or >140 mmHg systolic averaged from 2 or 3 blood
pressure measurements
fElevated depression defined as a score of 9 or greater on the CESD-11
gPM2.5 = Particulate matter ≤ 2.5 μm in diameter, 1 year moving average values
estimated using concentration estimated at closest 6x6km grid point to
participant residence using GIS-based spatio-temporal models
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potential outcome misclassification, if any, is likely small,
given that multiple imputation was performed to predict
incident ED status for men without ED data (39.6% in
Wave 1 and 13.6% in Wave 2), with similar results to
using non-imputed data. Importantly, selection bias was
also unlikely, given that pollutant exposures and charac-
teristics of men with and without ED information were
similar across both data collection waves (Additional
File 1: Table S1). Second, exposures were estimated
using spatio-temporal models created from ambient
monitor measurements that are imperfect measures of
personal exposures to ambient air pollution. However,
our exposure assessment method minimized exposure
error resulting from spatial variation in PM2.5 concen-
trations, as the distance of the grid point estimates to
residential addresses were minimal and substantially
less than would otherwise occur if more traditional
closest stationary ambient monitor concentrations were
used to assess exposures. Any remaining exposure error
would likely bias our odds ratios towards the null, as
shown by previous studies that show that chronic
health risks are underestimated using nearest monitor ex-
posures [44–46]. Third, ED status was ascertained using
self-reports of ED and medication use, which may result
in outcome misclassification, likely biasing our results to-
wards the null given its independence with pollutant ex-
posures and given our binary outcome. The study would
be improved by confirming ED status with clinical diagno-
sis. Fourth, the NSHAP study consisted of community
dwelling older adults, limiting its generalizability to youn-
ger men and institutionalized men. Lastly, there are a
number of confounding variables that could be included
in future studies that were not available for all participants
in this study, resulting in potential residual confounding.
Examples include an improved measure of individual SES
(beyond our use of education as an SES proxy), given its
association with both higher pollutant levels [47] and ED
[3], and more comprehensive information on medication
usage and underlying health conditions related to ED.
Important strengths of this study include our NSHAP
population, which is nationally representative of older
adults. In this study, we analyzed the impacts of PM2.5
on incident ED controlling for key participant-specific
demographic characteristics and accounting for medica-
tion use. This comprehensive characterization of each
participant allowed us to control for potential con-
founders and to investigate the possibility of effect modi-
fication on a participant specific basis. The longitudinal
nature of participant data also allowed us to capture
newly developed cases of ED and analyze the impact of
ambient air pollution on incident ED. Additionally, we
assessed PM2.5 exposures for each participant using
Geographic Information System (GIS) based spatio-
temporal models, which reduced exposure error in our
exposure estimates. Importantly, our findings were
robust to our method of analysis, with results from sev-
eral sensitivity analyses being qualitatively similar to
those for our main analysis.
Table 4 ORs (95% CIs) for Incident ED per IQR Increment of O3 and NO2
a
Moving Averages
1 year 2 year 3 year 4 year 5 year 6 year 7 year
O3
b (n = 375) 1.27 (0.89, 1.82) 1.29 (0.93, 1.79) 1.19 (0.86, 1.64) 1.20 (0.88, 1.65) 1.17 (0.87, 1.57) 1.24 (0.92, 1.68) 1.24 (0.92, 1.66)
NO2
c (n = 265) 1.10 (0.70, 1.71) 1.01 (0.64, 1.58) 1.07 (0.70, 1.63) 1.11 (0.70, 1.76) 1.10 (0.71, 1.72) 1.12 (0.71, 1.76) 1.02 (0.66, 1.59)
aIncident ED is defined as either replying yes to ED question or reporting ED medication use in Wave 2 but not in Wave 1; 125 men had incident ED with O3 data
available and 84 men had incident ED with NO2 data available; results given are ORs (95% Confidence Intervals); Logistic regression models include adjustment
for age, geographic region (West, Midwest, Central, South, Northeast), ethnic group, education (<H.S., H.S., College), current smoking status, obesity (BMI ≥30),
diabetes, depression, season, and median household income
bSummer (April-Sept) only, 1 year IQR = 8.21 ppb, 2 years IQR = 7.17 ppb, 3 years IQR = 7.13 ppb, 4 years IQR = 7.16 ppb, 5 years IQR = 6.77 ppb, 6 years
IQR = 6.96 ppb, 7 years IQR = 6.81 ppb
c1 year IQR = 7.49 ppb, 2 years IQR = 7.35 ppb, 3 years IQR =7.18 ppb, 4 years IQR = 7.82 ppb, 5 years IQR = 7.57 ppb, 6 years IQR = 7.80 ppb,
7 years IQR = 7.81 ppb




1 year 2 year 3 year 4 year 5 year 6 year 7 year
Base Modelc 1.08 (0.84, 1.40) 1.07 (0.84, 1.36) 1.08 (0.85, 1.35) 1.09 (0.87, 1.36) 1.08 (0.88, 1.34) 1.08 (0.88, 1.34) 1.08 (0.88, 1.32)
Adjusted Modeld 1.16 (0.87, 1.55) 1.16 (0.89, 1.53) 1.17 (0.90, 1.52) 1.17 (0.91, 1.50) 1.16 (0.91, 1.48) 1.16 (0.92, 1.47) 1.16 (0.92, 1.46)
aIncident ED is defined as either replying yes to ED question or reported ED medication usage in Wave 2 but not in Wave 1, multiple imputation using FCS
algorithm run 100 times, results given are mean ORs (95% Confidence Intervals)
bPM2.5 1 year IQR = 3.25 μg/m
3, 2 years IQR =3.12 μg/m3, 3 years IQR = 3.18 μg/m3, 4 years IQR = 3.12 μg/m3, 5 years IQR =3.10 μg/m3, 6 years IQR = 3.15 μg/m3,
7 years IQR = 3.10 μg/m3
cLogistic regression models include adjustment for age and geographic region (West, Midwest, Central, South, Northeast) in base models
dAdditional adjustment for ethnic group, education (<H.S., H.S., College), current smoking status, obesity, depression, diabetes, season, and median household
income in adjusted models
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Conclusions
In summary, we found positive associations between
recent long-term ambient PM2.5 levels and ED that did
not reach nominal statistical significance. The associations
were stronger for longer-term moving averages of expos-
ure. Given that our study is the first to examine associa-
tions between ambient air pollution and ED, further
research investigating the association of PM2.5 and inci-
dent ED should be conducted using larger sample sizes. If
the relationship between PM2.5 and incident ED does in
fact exist, limiting exposure to PM2.5 may decrease the
number of incident cases of ED in older men, a common
condition that affects an increasing number of men.
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Table 3 Effect Modification of the 4 Year Moving Average
PM2.5-Incident ED Association
a
Effect Modifier Odds Ratio (95% CI)
Obesity
BMI <30 kg/m2 1.14 (0.88, 1.46)
BMI ≥30 kg/m2 0.92 (0.74, 1.14)
CRP
Low (<1 mg/L) 1.19 (0.92, 1.52)
Elevated (≥1 mg/L) 0.92 (0.75, 1.14)
Diabetes
No 1.13 (0.86, 1.48)
Yes 0.94 (0.74, 1.19)
Hypertension
No 1.16 (0.91, 1.48)
Yes 1.03 (0.85, 1.24)
Depression
No 1.13 (0.84, 1.52)
Yes 0.95 (0.73, 1.23)
Exercise
None 1.16 (0.90, 1.49)
≥1 times/week 1.03 (0.83, 1.27)
Current smoker
No 1.19 (0.89, 1.61)
Yes 1.04 (0.80, 1.35)
aResults for Wave 2 with imputed data; Incident ED is defined as men who either
replied yes to ED question or reported ED medication usage in Wave 2; the
comparison group of men without ED replied no to the ED question and ED
medication use in both waves; logistic model includes adjustment for age,
geographic region, ethnic group, education (<H.S., H.S., College), current smoking
status, obesity, diabetes, depression, season, median household income;
Reference group is PM2.5 4 year moving average exposures (IQR =3.12 μg/m
3)
Tallon et al. Environmental Health  (2017) 16:12 Page 7 of 9
Received: 5 August 2016 Accepted: 8 February 2017
References
1. National Institutes of Health: NIH Consensus Conference. Impotence. NIH
consensus development panel on impotence. JAMA. 1993;270(1):83–90.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence
and its medical and psychosocial correlates: results of the Massachusetts
male aging study. J Urol. 1994;151(1):54–61.
3. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKINLAY JB.
Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal
results from the Massachusetts male aging study. J Urol. 2000;163(2):460–3.
4. Aytac I, McKinlay J, Krane R. The likely worldwide increase in erectile
dysfunction between 1995 and 2025 and some possible policy
consequences. BJU Int. 1999;84:50–6.
5. Hockenberry MS, Masson P. Erectile dysfunction in the elderly. Curr Geriatr
Rep. 2015;4(1):33–43.
6. De Boer B, Bots M, Nijeholt A, Verheij TJ. The prevalence of bother,
acceptance, and need for help in men with erectile dysfunction. J Sex Med.
2005;2(3):445–50.
7. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular
patient: endothelial dysfunction is the common denominator. Heart.
2003;89(3):251–3.
8. Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, Roger
VL, Jacobsen SJ. A population-based, longitudinal study of erectile
dysfunction and future coronary artery disease. Mayo Clinic Proceedings.
2009;84(2):108–113.
9. Albersen M, Orabi H, Lue TF. Evaluation and treatment of erectile
dysfunction in the aging male: a mini-review. Gerontology. 2012;58(1):3–14.
10. Elesber AA, Solomon H, Lennon RJ, Mathew V, Prasad A, Pumper G, Nelson
RE, McConnell JP, Lerman LO, Lerman A. Coronary endothelial dysfunction
is associated with erectile dysfunction and elevated asymmetric
dimethylarginine in patients with early atherosclerosis. Eur Heart J.
2006;27(7):824–31.
11. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R,
Mittleman M, Samet J, Smith Jr SC, Tager I. Expert panel on population and
prevention science of the american heart association: Air pollution and
cardiovascular disease: a statement for healthcare professionals from the
expert panel on population and prevention science of the american heart
association. Circulation. 2004;109(21):2655–71.
12. Brook RD, Rajagopalan S, 3rd Pope CA, Brook JR, Bhatnagar A, Diez-Roux AV,
Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith
Jr SC, Whitsel L, Kaufman JD, American Heart Association Council on
Epidemiology and Prevention, Council on the Kidney in Cardiovascular
Disease, and Council on Nutrition, Physical Activity and Metabolism.
Particulate matter air pollution and cardiovascular disease: an update to the
scientific statement from the american heart association. Circulation.
2010;121(21):2331–78.
13. 3rd Pope CA, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D,
Godleski JJ. Cardiovascular mortality and long-term exposure to particulate
air pollution: epidemiological evidence of general pathophysiological
pathways of disease. Circulation. 2004;109(1):71–7.
14. Donaldson K, Tran CL. Inflammation caused by particles and fibers. Inhal
Toxicol. 2002;14(1):5–27.
15. O’Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Economides PA,
Horton ES, Schwartz J. Diabetes enhances vulnerability to particulate air
pollution-associated impairment in vascular reactivity and endothelial
function. Circulation. 2005;111(22):2913–20.
16. O’Muircheartaigh C, Eckman S, Smith S. Statistical design and estimation for
the national social life, health, and aging project. J Gerontol Ser B Psychol
Sci Soc Sci. 2009;64B suppl 1:i12–9.
17. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative
weight and obesity. J Chronic Dis. 1972;25(6):329–43.
18. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz
T, Sheps SG, Roccella EJ. Subcommittee of professional and public
education of the american heart association council on high blood pressure
research: recommendations for blood pressure measurement in humans
and experimental animals: part 1: blood pressure measurement in humans:
a statement for professionals from the subcommittee of professional and
public education of the american heart association council on high blood
pressure research. Hypertension. 2005;45(1):142–61.
19. Hansson L, Lindquist L. C-reactive protein: its role in the diagnosis and
follow-up of infectious diseases. Curr Opin Infect Dis. 1997;10(3):196–201.
20. Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J. Two shorter forms of
the CES-D (Center for Epidemiological Studies Depression) depression
symptoms index. J Aging Health. 1993;5(2):179–93.
21. Harada N, Takeshita J, Ahmed I, Chen R, Petrovitch H, Ross GW, Masaki K.
Does cultural assimilation influence prevalence and presentation of
depressive symptoms in older Japanese American men? the Honolulu-Asia
aging study. Am J Geriatr Psychiatry. 2012;20(4):337–45.
22. Yanosky JD, Paciorek CJ, Laden F, Hart JE, Puett RC, Liao D, Suh HH. Spatio-
temporal modeling of particulate air pollution in the conterminous United
States using geographic and meteorological predictors. Environ Health.
2014;13(1):63.
23. Environmental Protection Agency (EPA). :http://www.epa.gov/ttn/airs/
airsaqs/.(2009) Accessed 27 Dec 2015
24. Interagency Monitoring of Protected Visual Environments (IMPROVE). :http://
vista.cira.colostate.edu/improve/.(2013) Accessed 27 Dec 2015
25. Lee KJ, Carlin JB. Multiple imputation for missing data: fully conditional
specification versus multivariate normal imputation. Am J Epidemiol. 2010;
171(5):624–32.
26. Keene LC, Davies PH. Drug-related erectile dysfunction. Adverse Drug React
Toxicol Rev. 1999;18(1):5–24.
27. Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJ.
Endothelial dysfunction in erectile dysfunction: role of the endothelium in
erectile physiology and disease. J Androl. 2003;24(S6):S17–37.
28. Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, Peters A. Effects of air
pollution on blood pressure: a population-based approach. Am J Public
Health. 2001;91(4):571–7.
29. Zanobetti A, Canner MJ, Stone PH, Schwartz J, Sher D, Eagan-Bengston E,
Gates KA, Hartley LH, Suh H, Gold DR. Ambient pollution and blood
pressure in cardiac rehabilitation patients. Circulation. 2004;110(15):2184–9.
30. Diez Roux AV, Auchincloss AH, Dvonch JT, Brown PL, Barr RG, Daviglus ML,
Goff Jr DC, Kaufman JD, O'Neill MS. Associations between recent exposure
to ambient fine particulate matter and blood pressure in the Multi-Ethnic
Study of Atherosclerosis. Environmental Health Perspectives. 2008;116(4):
486–91.
31. Wellenius GA, Schwartz J, Mittleman MA. Air pollution and hospital
admissions for ischemic and hemorrhagic stroke among medicare
beneficiaries. Stroke. 2005;36(12):2549–53.
32. Schneider A, Neas L, Herbst MC, Case M, Williams RW, Cascio W, Hinderliter
A, Holguin F, Buse JB, Dungan K. Endothelial dysfunction: associations with
exposure to ambient fine particles in diabetic individuals. Environ Health
Perspect. 2008;116(12):1666–74.
33. Künzli N, Jerrett M, Garcia-Esteban R, Basagaña X, Beckermann B, Gilliland F,
Medina M, Peters J, Hodis HN, Mack WJ. Ambient air pollution and the
progression of atherosclerosis in adults. PLoS One. 2010;5(2):e9096.
34. Diez Roux AV, Auchincloss AH, Franklin TG, Raghunathan T, Barr RG,
Kaufman J, Astor B, Keeler J. Long-term exposure to ambient particulate
matter and prevalence of subclinical atherosclerosis in the multi-ethnic
study of atherosclerosis. Am J Epidemiol. 2008;167(6):667–75.
35. Kaufman JD, Adar SD, Barr RG, Budoff M, Burke GL, Curl CL, Daviglus ML,
Roux AVD, Gassett AJ, Jacobs DR: Association between air pollution and
coronary artery calcification within six metropolitan areas in the USA (the
Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal
cohort study. The Lancet. 2016;388(10045):696–704.
36. Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation
of fine particulate air pollution and ozone causes acute arterial
vasoconstriction in healthy adults. Circulation. 2002;105(13):1534–6.
37. Bind MA, Baccarelli A, Zanobetti A, Tarantini L, Suh H, Vokonas P, Schwartz J.
Air pollution and markers of coagulation, inflammation, and endothelial
function: associations and epigene-environment interactions in an elderly
cohort. Epidemiology. 2012;23(2):332–40.
38. Zeka A, Sullivan JR, Vokonas PS, Sparrow D, Schwartz J. Inflammatory
markers and particulate air pollution: characterizing the pathway to disease.
Int J Epidemiol. 2006;35(5):1347–54.
39. Gillon G, Barnea O. Erection mechanism of the penis: a model based
analysis. J Urol. 2002;168(6):2711–5.
40. Kloner RA, Speakman M. Erectile dysfunction and atherosclerosis. Curr
Atheroscler Rep. 2002;4(5):397–401.
41. Vanhoutte P. Ageing and endothelial dysfunction. Eur Heart J-Suppl. 2002;4:
A8.
Tallon et al. Environmental Health  (2017) 16:12 Page 8 of 9
42. Nurkiewicz TR, Porter DW, Hubbs AF, Stone S, Chen BT, Frazer DG,
Boegehold MA, Castranova V. Pulmonary nanoparticle exposure disrupts
systemic microvascular nitric oxide signaling. Toxicol Sci.
2009;110(1):191–203.
43. Pope III CA, Dockery DW. Health effects of fine particulate air pollution: lines
that connect. J Air Waste Manage Assoc. 2006;56(6):709–42.
44. Suh HH, Zanobetti A. Exposure error masks the relationship between traffic-
related air pollution and heart rate variability. J Occup Environ Med.
2010;52(7):685–92.
45. Kioumourtzoglou M, Spiegelman D, Szpiro AA, Sheppard L, Kaufman JD,
Yanosky JD, Williams R, Laden F, Hong B, Suh H. Exposure measurement
error in PM2. 5 health effects studies: A pooled analysis of eight personal
exposure validation studies. Environ Health. 2014;13(1):2.
46. Paciorek CJ, Yanosky JD, Puett RC, Laden F, Suh HH. Practical large-scale
spatio-temporal modeling of particulate matter concentrations. The Annals
of Applied Statistics. 2009;3(1):370–97.
47. Hajat A, Diez-Roux AV, Adar SD, Auchincloss AH, Lovasi GS, O’Neill MS,
Sheppard L, Kaufman JD. Air pollution and individual and neighborhood
socioeconomic status: evidence from the Multi-Ethnic Study of
Atherosclerosis (MESA). Environ Health Perspect (Online). 2013;121(11–12):
1325.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Tallon et al. Environmental Health  (2017) 16:12 Page 9 of 9
